Smartlab Europe

Press Releases

Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services

Co-Diagnostics Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that it has entered into an agreement with Arches Research, Inc, a CLIA laboratory and subsidiary of Polarity TE, Inc, to...

INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that Thermo Fisher Scientific, the world leader in serving science, has signed a letter of...

PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line

PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced on August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Development and Manufacturing Organization) company in Korea. With the new...

Catalent and Exelixis Enter into Collaboration, License, and Exclusive Option Agreement to Develop ADC Leveraging SMARTag Bioconjugation Technology

Exelixis, Inc. and Catalent announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates (ADCs) for Exelixis using Catalent’s proprietary SMARTag® site-specific bioconjugation technology. Under the terms of the agreement, Catalent will use its SMARTag® bioconjugation...

Sharp launches Clinventory Inventory Management System (IMS) for clinical trials

Sharp - part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS) to support clinical trial sponsors in managing inventory and supplies. The new system - named Clinventory...

Enesi Pharma partners with Adelaide University for Zika vaccine

Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection...

AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an innovative anti-CD47 monoclonal antibody internally discovered and developed by I-Mab for the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »